Immunization Practices for Children in Child Care Group Settings
[38 Pa.B. 4830]
[Saturday, August 30, 2008]
In accordance with 28 Pa. Code § 27.77(c) (relating to immunization requirements for children in child care group settings), the Department of Health (Department), Bureau of Communicable Diseases, Division of Immunization, is updating the list of Morbidity and Mortality Weekly Report (MMWR) publications that contain the Advisory Committee on Immunization Practices (ACIP) recommendations that meet the standards of 28 Pa. Code § 27.77(c). Children in child care group settings as defined by 28 Pa. Code § 27.77(c) are required to be immunized in accordance with the recommendations included in the following publications. The Department is providing a summary of the publications for the ease of reference of the public:
Summary of Selected MMWR Articles on Pediatric/Adolescent Immunizations
(Morbidity and Mortality Weekly Report)
January 11, 2008/Vol. 57/No. 1
Recommended Immunization Schedules for Persons Aged 0--18 Years--United States, 2008
The ACIP annually publishes a recommended immunization schedule for persons aged 0--18 years to reflect changes in vaccine formulations and current recommendations for the use of licensed vaccines. Visit the following link to view or download the updated schedule: www.cdc.gov/vaccines/recs/schedules/child-schedule.htm#printable.
February 22, 2008/Vol. 57/No. 7
Multistate Measles Outbreak Associated with an International Youth Sporting Event--Pennsylvania, Michigan and Texas, August--September 2007
Measles, a highly infectious viral illness, is no longer endemic in the United States because of high coverage rates with an effective vaccine. However, imported cases continue to cause illness and outbreaks among susceptible United States residents. In August 2007, a participant in an international youth sporting event who traveled from Japan to the United States became ill with measles. Because he traveled while infectious to an event with thousands of participants and spectators, an outbreak investigation was conducted in multiple states by state and local health departments in coordination with CDC, using standard measles surveillance case definitions and classifications. This report summarizes the results of that investigation, which identified six additional measles cases that were linked epidemiologically to the index case and two generations of secondary transmission.
February 22, 2008/Vol. 57/No. 7
Update: Influenza Activity--United States, September 30, 2007--February 9, 2008
This report summarizes United States influenza activity since the beginning of the 2007-2008 influenza season (September 30, 2007) and updates the previous summary. From September through early December, influenza activity remained low in the United States. Activity increased from early December through the end of the year and has continued to increase in January and February.
March 14, 2008/Vol. 57/No. 10
Update: Recommendations from the ACIP Regarding Administration of Combination MMRV Vaccine
On February 27, 2008, new information was presented to the ACIP regarding the risk for febrile seizures among children aged 12--23 months after administration of the combination measles, mumps, rubella and varicella (MMRV) vaccine (ProQuad®, Merck & Co., Inc., White- house Station, NJ). This report summarizes current knowledge regarding the risk for febrile seizures after MMRV vaccination and presents updated ACIP recommendations that were issued after presentation of the new information. These updated recommendations remove ACIP's previous preference for administering combination MMRV vaccine over separate injections of equivalent component vaccines (that is, measles, mumps, and rubella (MMR) vaccine and varicella vaccine).
April 4, 2008/Vol. 57/No. 13
Updated Recommendation from the ACIP for Use of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24--59 Months Who Are Not Completely Vaccinated
This notice updates the recommendation for use of PCV7 among children aged 24--59 months who are either unvaccinated or who have a lapse in PCV7 administration. In February 2000, PCV7, marketed as Prevnar® and manufactured by Wyeth Vaccines (Collegeville, PA), was approved by the Food and Drug Administration for use in infants and young children. At that time, the ACIP recommended that children aged 24--59 months who have certain underlying medical conditions or are immunocompromised receive PCV7. In addition, ACIP recommended that PCV7 be considered for all other children aged 24--59 months, with priority given to those who are American Indian/Alaska Native or of African-American descent, and to children who attend group day care centers.
April 18, 2008/Vol. 57/No. 15
Rotavirus Vaccination Coverage and Adherence to the ACIP--Recommended Vaccination Schedule--United States, February 2006--May 2007
Worldwide, rotavirus is the leading cause of severe gastroenteritis in children aged <5 years. In February 2006, a new human-bovine rotavirus vaccine, RotaTeq® (Merck & Co., Inc., Whitehouse Station, NJ), was recommended by the ACIP for routine vaccination of United States. infants.
May 2, 2008/Vol. 57/No. 17
Syncope After Vaccination--United States, January 2005--July 2007
Syncope (vasovagal reaction), or fainting, can be triggered by various stimuli, including medical procedures. Syncope has been documented to occur after vaccination, most commonly among adolescents, and can result in hospitalization for a medical evaluation or because of injury.
Report from the ACIP: Decision Not to Recommend Routine Vaccination of All Children Aged 2--10 Years with Quadrivalent Meningococcal Conjugate Vaccine
At its February 2008 meeting, the ACIP decided not to recommend routine vaccination of children aged 2--10 years against meningococcal disease unless the child is at increased risk for the disease. This report summarizes the deliberations of ACIP and the rationale for its decision and restates existing recommendations for meningococcal vaccination among children aged 2--10 years at increased risk for meningococcal disease. ACIP continues to recommend routine vaccination against meningococcal disease for all persons aged 11--18 years and those persons aged 2--55 years who are at increased risk for meningococcal disease.
May 9, 2008/Vol. 57/No. 18
Measles--United States, January 1--April 25, 2008
Measles, a highly contagious acute viral disease, can result in serious complications and death. As a result of a successful U.S. vaccination program, measles elimination (that is, interruption of endemic measles transmission) was declared in the United States in 2000.
June 27, 2008/Vol. 57/No. 25
Influenza Activity--United States and Worldwide, 2007-2008 Season
During the 2007--2008 influenza season, influenza activity peaked in mid-February in the United States and was associated with greater mortality and higher rates of hospitalization of children aged 0--4 years, compared with each of the previous three seasons.
Delayed Onset and Diminished Magnitude of Rotavirus Activity--United States, November 2007--May 2008
On June 25, this report was posted as an MMWR Early Release on the MMWR web site www.cdc.gov/mmwr.
Rotavirus is the leading cause of severe acute gastroenteritis among infants and young children, accounting for an estimated 527,000 deaths among children aged <5 years worldwide in 2004. In the United States, rotavirus causes few deaths (20--60) each year, but remains a substantial cause of morbidity among children, resulting in approximately 55,000--70,000 hospitalizations, 205,000--272,000 emergency department visits, and 410,000 physician office visits.
July 25, 2008/Vol. 57/No. 29
Use of Mass Tdap Vaccination to Control an Outbreak of Pertussis in a High School--Cook County, Illinois, September 2006--January 2007
On September 6, 2006, the Cook County Department of Public Health was notified that a local high school student aged 17 years had pertussis. During September 2006--January 2007, 36 pertussis cases directly linked to the high school were identified. Because Bordetella pertussis immunity from childhood vaccinations wanes over time, outbreaks of pertussis can periodically occur among students and staff at middle and high schools.
August 1, 2008/Vol. 57/No. 30
Newborn Hepatitis B Vaccination Coverage Among Children Born January 2003--June 2005--United States
Hepatitis B vaccine was first recommended for administration to all infants in 1991 by the ACIP as the primary focus of a strategy to eliminate hepatitis B virus (HBV) transmission in the United States.
Additional information relating to vaccinations may be obtained from the Department's web site at www.dsf. health.state.pa.us/health and from the National Immunization Program of the Centers for Disease Control and Prevention at the following web site www.cdc.gov/nip/default.htm.
Persons with a disability who require an alternative format of this notice (for example, large print, audiotape, Braille) should contact Heather Stafford, Director, Department of Health, Division of Immunization, Room 1026, Health and Welfare Building, Harrisburg, PA 17120-0701, (717) 787-5681 or for speech and/or hearing impaired persons at V/TT (717) 783-6154 or the Pennsylvania AT&T Relay Service at (800) 654-5984 (TT).
CALVIN B. JOHNSON, M. D., M.P.H.,
[Pa.B. Doc. No. 08-1605. Filed for public inspection August 29, 2008, 9:00 a.m.]
No part of the information on this site may be reproduced for profit or sold for profit.
This material has been drawn directly from the official Pennsylvania Bulletin full text database. Due to the limitations of HTML or differences in display capabilities of different browsers, this version may differ slightly from the official printed version.